医学
围手术期
分流器
狭窄
危险系数
优势比
倾向得分匹配
内科学
心脏病学
糖皮质激素
多中心试验
前瞻性队列研究
随机对照试验
队列
队列研究
外科
动脉瘤
麻醉
临床试验
多中心研究
闭塞
作者
Zhuohua Wen,Xiheng Chen,Xin Tong,Chi Huang,Mengshi Huang,Jiancheng Lin,Anqi Xu,Hanyan Yang,Xiru Zhang,Yuanqi Lin,Jiwan Huang,Runze Ge,Hao Yuan,Chao Peng,Yanchao Liu,Fa Jin,苏世星,Xin Zhang,Xifeng Li,Zongduo Guo
标识
DOI:10.1038/s41467-026-78408-w
摘要
Flow diverter (FD) implantation is standard for unruptured intracranial aneurysms (UIAs), but cerebrovascular complications persist. This nested study within a prospective multicenter cohort evaluates whether short-term, low-dose glucocorticoid use is associated with cerebrovascular outcomes after FD implantation. Propensity-score matching with exact matching on UIA location yielded 1327 patients (360 glucocorticoid-treated; 967 controls). Intravenous glucocorticoids, initiated within 2 hours of the FD procedure and administered for ≥2 days, were associated with fewer in-hospital cerebrovascular events (6.9% vs. 13.1%; adjusted odds ratio [aOR], 0.53) and major cerebrovascular events (4.7% vs. 12.4%; aOR, 0.37). Over a median 2-year follow-up, glucocorticoid use was also associated with fewer new-onset major cerebrovascular events (3.6% vs. 8.7%; adjusted hazard ratio, 0.41) and less in-stent stenosis (7.9% vs. 13.2%; aOR, 0.55). Findings remained robust in unmatched patients on sensitivity analyses. We demonstrate that perioperative glucocorticoid regimens may reduce cerebrovascular events and in-stent stenosis in FD-treated patients, warranting randomized trials.
科研通智能强力驱动
Strongly Powered by AbleSci AI